{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:23:33Z","timestamp":1772796213208,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"DOI":"10.7759\/cureus.104756","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:31:50Z","timestamp":1772789510000},"source":"Crossref","is-referenced-by-count":0,"title":["The Diabetic Catalyst: A Rapid 12-Month Evolution of Hepatic Stiffness in a South Indian Cohort With Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.7759","author":[{"given":"Roopa S","family":"Nibbaragandla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan Sai","family":"Nelluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SreeRam","family":"Thiriveedhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitanya L","family":"Narra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha S","family":"Palagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Ginjupalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chebrolu","family":"Harshitha Chowdary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023, 78:1966-86. 10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","unstructured":"Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, Goel A. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022, 12:818-29. 10.1016\/j.jceh.2021.11.010","journal-title":"J Clin Exp Hepatol"},{"key":"ref4","article-title":"Prevalence of non-alcoholic fatty liver disease in newly diagnosed type 2 diabetes mellitus","volume":"14","author":"Akhtar Z","year":"2024","unstructured":"Akhtar Z, Agarwal PK, Singh MP. Prevalence of non-alcoholic fatty liver disease in newly diagnosed type 2 diabetes mellitus. Eur J Cardiovasc Med. 2024, 14:745-9.","journal-title":"Eur J Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18203\/2394-6040.ijcmph20254434","article-title":"Prevalence of non-alcoholic fatty liver disease using surrogate indices among adults attending a tertiary care hospital in Eastern India","volume":"13","author":"Naik LP","year":"2025","unstructured":"Naik LP, Rath M, Sunandini D, Sahu SP. Prevalence of non-alcoholic fatty liver disease using surrogate indices among adults attending a tertiary care hospital in Eastern India. Int J Community Med Public Health. 2025, 13:256-8. 10.18203\/2394-6040.ijcmph20254434","journal-title":"Int J Community Med Public Health"},{"key":"ref6","article-title":"IDF Diabetes Atlas","author":"IDF Diabetes Atlas 11th Edition Committee","year":"2025","unstructured":"IDF Diabetes Atlas 11th Edition Committee. IDF Diabetes Atlas, 11th Edition. Magliano DJ, Boyko EJ, Genitsaridi I, Piemonte L, Riley P, Salpea P (ed): International Diabetes Federation, Brussels, Belgium; 2025. https:\/\/diabetesatlas.org\/media\/uploads\/sites\/3\/2025\/04\/IDF_Atlas_11th_Edition_2025.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","volume":"91","author":"Sanders FW","year":"2016","unstructured":"Sanders FW, Griffin JL. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc. 2016, 91:452-68. 10.1111\/brv.12178","journal-title":"Biol Rev Camb Philos Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg H","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010, 52:836-46. 10.1002\/hep.24001","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida T","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017, 14:397-411. 10.1038\/nrgastro.2017.38","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2016.06.005","article-title":"Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus","volume":"45","author":"Bril F","year":"2016","unstructured":"Bril F, Cusi K. Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus. Endocrinol Metab Clin North Am. 2016, 45:765-81. 10.1016\/j.ecl.2016.06.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref11","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus and its correlation with glycemic control at a private referral hospital in northern Gujarat","volume":"15","author":"Raval YB","year":"2025","unstructured":"Raval YB, Rajput DHV, Chaudhary VD. Prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus and its correlation with glycemic control at a private referral hospital in northern Gujarat. Eur J Cardiovasc Med. 2025, 15:215-8.","journal-title":"Eur J Cardiovasc Med"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg H","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017, 14:32-42.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2602995","article-title":"Global epidemiology of diabetes and prediabetes in lean or non-obese patients with NAFLD: a systematic review and meta-analysis","volume":"58","author":"Li YY","year":"2026","unstructured":"Li YY, Yu Y, Jing HB, et al.. Global epidemiology of diabetes and prediabetes in lean or non-obese patients with NAFLD: a systematic review and meta-analysis. Ann Med. 2026, 58:1. 10.1080\/07853890.2025.2602995","journal-title":"Ann Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD)","volume":"28","author":"Cusi K","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, et al.. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022, 28:528-62. 10.1016\/j.eprac.2022.03.010","journal-title":"Endocr Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al.. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006, 43:1317-25. 10.1002\/hep.21178","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso M","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, et al.. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010, 36:1825-35. 10.1016\/j.ultrasmedbio.2010.07.005","journal-title":"Ultrasound Med Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed NA","year":"2024","unstructured":"ElSayed NA, Aleppo G, Bannuru RR, et al.. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 2024, 47:S20-42. 10.2337\/dc24-S002","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani N","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018, 67:328-57. 10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"ref19","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra A","year":"2009","unstructured":"Misra A, Chowbey P, Makkar BM, et al.. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009, 57:163-70.","journal-title":"J Assoc Physicians India"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera L","year":"2008","unstructured":"Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008, 48:835-47. 10.1016\/j.jhep.2008.02.008","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee QM","year":"2013","unstructured":"Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013, 10:330-44.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome\u2014position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology","volume":"5","author":"Duseja A","year":"2015","unstructured":"Duseja A, Singh SP, Saraswat VA, et al.. Non-alcoholic fatty liver disease and metabolic syndrome\u2014position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015, 5:51-68. 10.1016\/j.jceh.2015.02.006","journal-title":"J Clin Exp Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464722-the-diabetic-catalyst-a-rapid-12-month-evolution-of-hepatic-stiffness-in-a-south-indian-cohort-with-metabolic-dysfunction-associated-steatotic-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:31:51Z","timestamp":1772789511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464722-the-diabetic-catalyst-a-rapid-12-month-evolution-of-hepatic-stiffness-in-a-south-indian-cohort-with-metabolic-dysfunction-associated-steatotic-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.104756","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,6]]}}}